All In Biotech

Drug Trial Radar · NCT06285799

Safety and Effectiveness of Iron Hydroxide Adipate Tartrate (IHAT) in Iron Deficient Premenopausal Women

A Randomised, Double-blind Study to Determine the Safety and Efficacy of Iron Hydroxide Adipate Tartrate (IHAT) in Iron Deficient Premenopausal Women

Last checked: Nov 19, 2026Latest source record: Jun 4, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. Randomized with 180 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

180

Actual

Start

Mar 5, 2024

Primary completion

Feb 11, 2025

Study completion Feb 15, 2025

Sponsor

Lead sponsor
Nemysis LtdIndustry
Sponsor type
Industry
Collaborators
RDC Clinical Pty Ltd
First posted
Feb 29, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
Female only, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a double blind, randomised, placebo-controlled trial to evaluate orally-dosed Iron Hydroxide Adipate Tartrate (IHAT) at 2 different dose levels compared to placebo for increasing serum ferritin levels in iron deficient, but otherwise healthy premenopausal women over 12 weeks.

Conditions

  • Iron-deficiency

Interventions

  • Low Dose IHATDrug

    Once daily dose of 1 IHAT capsule (100mg IHAT per capsule) and once daily dose of 1 placebo capsule (carob flour)

  • High Dose IHATDrug

    Twice daily dose of 1 IHAT capsule (100mg IHAT per capsule)

  • Carob FlourDrug

    Twice daily dose of 1 placebo capsule (carob flour)

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percentage of women recovering from iron deficiency at week 12Time frame: week 12

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • RDC Clinical Pty Ltd

    Brisbane, Queensland, Australia

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.